| DESCRIPTION | - E. MEYERS; W. MILLER, CABIOS, (1989), vol. 4, pages 11 - 17 | - |
| DESCRIPTION | - HEIER J.S. ET AL., AM. ACAD. OPTHALMOL., (2012), vol. 119, page 2537 | - |
| DESCRIPTION | - NEEDLEMAN; WUNSCH, J. MOL. BIOL., (1970), vol. 48, pages 444 - 453 | - |
| INTERNATIONAL-SEARCH-REPORT | - PETER FRANCIS, "The influence of genetics on response to treatment with ranibizumab (Lucentis) for age-related macular degeneration: the Lucentis Genotype Study (an American Ophthalmological Society thesis).", TRANSACTIONS OF THE AMERICAN OPHTHALMOLOGICAL SOCIETY ANNUAL MEETING, (20111201), vol. 109, ISSN 0065-9533, pages 115 - 156, XP055075876 [A] 1-21,25-45 * abstract * | - |
| INTERNATIONAL-SEARCH-REPORT | - VINSON M. WANG ET AL, "Suggestive association between PLA2G12A single nucleotide polymorphism rs2285714 and response to anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration", MOLECULAR VISION, (20121020), vol. 18, ISSN 1090-0535, pages 2578 - 2585, XP055146483 [X] 1,9,25,33 * abstract * | - |
| INTERNATIONAL-SEARCH-REPORT | - KAWASHIMA YU ET AL, "Effects of aflibercept for ranibizumab-resistant neovascular age-related macular degeneration and polypoidal choroidal vasculopathy", GRAEFE'S ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, SPRINGER VERLAG, DE, vol. 253, no. 9, doi:10.1007/S00417-014-2838-5, ISSN 0721-832X, (20141113), pages 1471 - 1477, (20141113), XP035528379 [X] 9,33 * page 1472, column r, paragraph 3 * | |
| INTERNATIONAL-SEARCH-REPORT | - MICHAEL B GORIN, "Genetic insights into age-related macular degeneration: Controversies addressing risk, causality, and therapeutics", MOLECULAR ASPECTS OF MEDICINE, vol. 33, no. 4, doi:10.1016/J.MAM.2012.04.004, ISSN 0098-2997, (20120427), pages 467 - 486, (20120427), XP028400782 [A] 1-21,25-45 * page 478, paragraph 1 * | |
| INTERNATIONAL-SEARCH-REPORT | - FARSHAD ABEDI ET AL, "Variants in the VEGFA Gene and Treatment Outcome after Anti-VEGF Treatment for Neovascular Age-related Macular Degeneration", OPHTHALMOLOGY, (20130101), vol. 120, no. 1, doi:10.1016/j.ophtha.2012.10.006, ISSN 0161-6420, pages 115 - 121, XP055075853 [X] 9,33 * page 117, column l, paragraph 6 * | |
| INTERNATIONAL-SEARCH-REPORT | - AGOSTA E ET AL, "Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration", PHARMACOGENOMICS,, (20120701), vol. 13, no. 9, doi:10.2217/PGS.12.77, ISSN 1462-2416, pages 1037 - 1053, XP008164305 [X] 9,33 * page 1042, column r, paragraph 2 * | |
| OPPOSITION | - Anonymous, "Age-Related Macular Degeneration: Guidelines for Management", The Royal College of Ophthalmologists, (20130901), pages 1 - 145, XP055973162 | - |
| OPPOSITION | - Anonymous, "A/G single-nucleotide variation on chromosome X", PUBMED, (20010412), Database accession no. rs2056688, XP093188871 | - |
| OPPOSITION | - Anonymous, "A/G single-nucleotide variation on chromosome X", PUBMED, (20030421), Database accession no. rs5962084, XP093188874 | - |
| OPPOSITION | - Anonymous, "A/G/T single nucleotide variation on chromosome X", PUBMED, (20030421), Database accession no. rs5962095, XP093188884 | - |
| OPPOSITION | - Anonymous, "C/G/T single-nucleotide variation on chromosome X", PUBMED, (20030421), Database accession no. rs5962087, XP093188880 | - |
| OPPOSITION | - Anonymous, "C/T single nucleotide variation on chromosome X", PUBMED, (20030421), Database accession no. rs5915722, XP093188882 | - |
| OPPOSITION | - Anonymous, "Die Anti-VEGF-Therapie bei der neovaskulären altersabhängigen Makuladegeneration: Therapeutische Strategien", Stellungnahme der Deutschen Ophthalmologischen Gesellschaft, der RetinologIschen Gesellschaft und des Berufsverbandes der Augenärzte Deutschlands, (20141101), XP093189918 | - |
| OPPOSITION | - Anonymous, "Erteilung einer Zulassung für das Humanarzneimittel "Eylea - Aflibercept"", EUROPÄISCHE KOMMISSION; DURCHFÜHRUNGSBESCHLUSS DER KOMMISSION; gemäß der Verordnung (EG) Nr. 726/2004 des Europäischen Parlaments und des Rates, EUROPÄISCHE KOMMISSION; DURCHFÜHRUNGSBESCHLUSS DER KOMMISSION; gemäß der Verordnung (EG) Nr. 726/2004 des Europäischen Parlaments und des Rates, XP093189914 | - |
| OPPOSITION | - Anonymous, "Human hg38 chrX:4148602-4148802 UCSC Genome Browser v467", UCSC Genome Browser, (20131201), Database accession no. rs2056688 , XP093188831 | - |
| OPPOSITION | - Anonymous, "Human hg38 chrX:4166747-4166947 UCSC Genome Browser v467", UCSC Genome Browser, (20131201), Database accession no. rs5962084 , XP093188834 | - |
| OPPOSITION | - Anonymous, "Human hg38 chrX:4186101-4186301 UCSC Genome Browser v467", UCSC Genome Browser, (20131201), Database accession no. rs5962087 , XP093188836 | - |
| OPPOSITION | - Anonymous, "Human hg38 chrX:4194672-4194872 UCSC Genome Browser v467", UCSC Genome Browser, (20131201), Database accession no. rs5915722 , XP093188837 | - |
| OPPOSITION | - Anonymous, "Human hg38 chrX:4201719-4201919 UCSC Genome Browser v467", UCSC Genome Browser, (20131201), Database accession no. rs5962095 , XP093188839 | - |
| OPPOSITION | - Anonymous, "Lucentis 10 mg/ml solution for injection - ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ", European Medicines Agency, (20120124), XP093188890 | - |
| OPPOSITION | - Anonymous, "Preferred Practice Pattern® Age-Related Macular Degeneration", American Academy of Ophthalmology, (20140920), XP093189915 | - |
| OPPOSITION | - Anonymous, " PRODUCT MONOGRAPH - EYLEA® Aflibercept", BAYER, BAYER, XP093189907 | - |
| OPPOSITION | - Anonymous, "rs2056688", dbSNP , (20220921), Database accession no. rs2056688 , XP093188791 | - |
| OPPOSITION | - Anonymous, "rs2056688 (SNP) - Population genetics - Homo_sapiens", Ensembl , (20240501), Database accession no. rs2056688 , XP093188816 | - |
| OPPOSITION | - Anonymous, "rs5915722 (SNP) - Population genetics - Homo_sapiens", Ensembl , (20240501), Database accession no. rs5915722 , XP093188823 | - |
| OPPOSITION | - Anonymous, "rs5917522", dbSNP , (20220921), Database accession no. rs5917522, XP093188802 | - |
| OPPOSITION | - Anonymous, "rs5962084", dbSNP , (20220921), Database accession no. rs5962084 , XP093188795 | - |
| OPPOSITION | - Anonymous, "rs5962084 (SNP) - Population genetics - Homo_sapiens", Ensembl , (20240501), Database accession no. rs5962084 , XP093188818 | - |
| OPPOSITION | - Anonymous, "rs5962087", dbSNP , (20220921), Database accession no. rs5962087, XP093188799 | - |
| OPPOSITION | - Anonymous, "rs5962087 (SNP) - Population genetics - Homo_sapiens", Ensembl , (20240501), Database accession no. rs5962087 , XP093188821 | - |
| OPPOSITION | - Anonymous, "rs5962095 ", dbSNP , (20220921), Database accession no. rs5962095 , XP093188805 | - |
| OPPOSITION | - Anonymous, "rs5962095 (SNP) - Population genetics - Homo_sapiens", Ensembl , (20240501), Database accession no. rs5962095 , XP093188826 | - |
| OPPOSITION | - Bayer, "Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD) (VIEW 2)", ClinicalTrials.gov, NLM, (20141212), pages 1 - 14, ClinicalTrials.gov, URL: https://clinicaltrials.gov/study/NCT00637377, XP093188759 | - |
| OPPOSITION | - D65-Declaration of Mr Peter Addison, Consultant Ophthalmic Surgeon at Moorfields Eye Hospital, London | - |
| OPPOSITION | - D66-Declaration of Professor Andrea Jorgensen, Professor of Biostatistics in the Department of Health Data Science at the University of Liverpool | - |
| OPPOSITION | - D67-NCI Dictionary of Genetic Terms for the term “variant” | - |
| OPPOSITION | - Eric Chen, Angeline F. Mariani, David M. Brown, "The Superdose Anti-VEGF (SAVE) Trial: 2.0-mg Intravitreal Ranibizumab for Recalcitrant Neovascular AMD, Two Year Endpoint Results", Investigative Ophthalmology & Visual Science, Association for Research in Vision and Ophthalmology, US, US , (20120301), vol. 53, no. 14, ISSN 0146-0404, page 2032, XP009556430 | - |
| OPPOSITION | - Guymer Robyn H., Rufino Silva; Mercedeh Ghadessi; Sergio Leal; Isabella Gashaw; Amy Damask; Charles Paulding; Kay D. Rittenhouse, "Genetic variants in ANO2 may be predictive for treatment response to anti-VEGF in neovascular age-related macular degeneration", Investigative Opthalmology & Visual Science, Association for Research in Vision and Ophthalmology, US, US , (20220601), vol. 63, no. 7, ISSN 1552-5783, pages 1495 - 1495, XP093188741 | - |
| OPPOSITION | - Heier Jeffery S., "Intravitreal Aflibercept for AMD: 2-year Results", Retina Today, (20120301), vol. 2012, no. 2, pages 49 - 51, XP093188747 | - |
| OPPOSITION | - Mckibbin M Gb Com, Devonpoort H., Gale R., Gavin M., Lotery A., Mahmood S., Patel P.J., Ross A., Sivaprasad S., Talks J., Walters G., "Aflibercept in wet AMD beyond the first year of treatment: recommendations by an expert roundtable panel", Eye, (20150701), vol. 29, no. suppl. 1, pages S1 - S11, XP055973584 | - |
| OPPOSITION | - Park Un Chul, Shin Joo Young, Mccarthy Linda C, Kim Sang Jin, Park Jung Hyun, Chung Hum, Gon Hyeong, "Pharmacogenetic associations with long-term response to antivascular endothelial growth factor treatment in neovascular AMD patients", MOLECULAR VISION, Molecular Vision, US, US , (20141219), vol. 20, ISSN 1090-0535, pages 1680 - 1694, XP093188781 | - |
| OPPOSITION | - Perlee Lorah T, Holekamp Nancy, "Identification of Genetic Variants Associated with Anti-VEGF Drug Response in Neovascular AMD Patients in the VIEW Trial", ARVO Annual Meeting Abstract, (20160901), XP093188870 | - |
| OPPOSITION | - Perlee Lorah T., Nancy Holekamp, "Identification of Genetic Variants Associated with Anti-VEGF Drug Response in Neovascular AMD Patients in the VIEW Trial", Investigative Ophthalmology & Visual Science, Association for Research in Vision and Ophthalmology, US, US , (20160901), vol. 57, no. 12, ISSN 0146-0404, pages 2639 - 2639, XP093188765 | - |
| OPPOSITION | - Peter Francis, "The influence of genetics on response to treatment with ranibizumab (Lucentis) for age-related macular degeneration: the Lucentis Genotype Study (an American Ophthalmological Society thesis).", Transactions of the American Ophthalmological Society annual meeting, American Ophthalmological Society, (20111201), vol. 109, ISSN 00659533, pages 115 - 156, XP055075876 | - |
| OPPOSITION | - Regeneron Pharmaceuticals, "Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD) (VIEW1)", ClinicalTrials.gov, NLM, (20121228), pages 1 - 11, ClinicalTrials.gov, URL: https://clinicaltrials.gov/study/NCT00509795, XP093188754 | - |
| OPPOSITION | - Ursula Schmidt,Erfurth,, Peter K. Kaiser, Md,2 Jean,Frar1fois Korobelnik, Md,3 David M. Brown, Md,4 Victor Chong, Md,5 Quan Dong Nguyen, Md,6 Allen C. Ho, Md,7 Yuichiro Ogura, Md,8 Christian Simader, Md, 1 Glenn]. Jaffe, Md,9 Jason S. Slakter, Md, 10 George D. Yancopoulos, Md, Phd, 11 Neil Stahl, Phd, 11 Robert Vitti, Md, 1 Allsonj. Berliner, Md, Phd, 11 Yuhwensoo, Phd, 11 Majidanderesi, Md, 12 Olaf Sowade, Md, 12 Oliver Zeitz, Md, 1 •13 Christiane Norenberg, Ms, 12 Rupert Sandbrink, Md, Phd, 12 •14 Jeffrey S. Heier, Md15, "Intravitreal Aflibercept Injection for N eovascular Age-related Macular Degeneration", OPHTHALMOLOGY, (20140101), vol. 121, no. 1, pages 193 - 201, XP055972253 | - |
| OPPOSITION | - Usha Chakravarthy, Simon P Harding, Chris A Rogers, Susan M Downes, Andrew J Lote,Y, Lucy A Culliford, Barnaby C Reeves, "Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial", THE LANCET, (20131012), vol. 382, pages 1258 - 1267, XP055972176 | - |
| OPPOSITION | - Vinson M. Wang, Et Al, "Suggestive association between PLA2G12A single nucleotide polymorphism rs2285714 and response to anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration", Molecular vision, (20121020), vol. 18, ISSN 10900535, pages 2578 - 2585, XP055146483 | - |
| OPPOSITION | - Bhagwat Medha, "Searching NCBI's dbSNP Database", Current Protocols in Bioinformatics, (20101201), vol. 32, no. 1, doi:10.1002/0471250953.bi0119s32, ISSN 1934-3396, XP093189921 | |
| OPPOSITION | - García-Layana Alfredo, Figueroa Marta S., Araiz Javier, Ruiz-Moreno José M., Gómez-Ulla Francisco, Arias-Barquet Luis, Reiter Nicholas, "Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept", Drugs & Aging, Adis International Ltd., AUCKLAND,NEW ZENLAND, AUCKLAND,NEW ZENLAND , (20151001), vol. 32, no. 10, doi:10.1007/s40266-015-0300-y, ISSN 1170-229X, pages 797 - 807, XP093188895 | |
| OPPOSITION | - Jeffrey S. Heier; David Boyer; Quan Dong Nguyen; Dennis Marcus; Daniel B. Roth; George Yancopoulos; Neil Stahl; Avner Ingerman; Robert Vitti; Alyson J. Berliner; Ke Yang; David M. Brown;, "The 1-year Results of CLEAR-IT 2, a Phase 2 Study of Vascular Endothelial Growth Factor Trap-Eye Dosed As-needed After 12-week Fixed Dosing", Ophthalmology, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (20110315), vol. 118, no. 6, doi:10.1016/j.ophtha.2011.03.020, ISSN 0161-6420, pages 1098 - 1106, XP028372935 | |
| OPPOSITION | - Jeffrey S. Heier, David M. Brown, Victor Chong, Jean-Francois Korobelnik, Peter K. Kaiser, Quan Dong Nguyen, Bernd Kirchhof, Allen Ho, Yuichiro Ogura, George D. Yancopoulos, Neil Stahl, Robert Vitti, Alyson J. Berliner, Yuhwen Soo, Majid Anderesi, Georg Groetzbach, Bernd Sommerauer, Rupert Sandbrink, Christian Simader, Ursula Schmidt-Erfurth, "Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration", Ophthalmology, Elsevier, (20121201), vol. 119, no. 12, doi:10.1016/j.ophtha.2012.09.006, ISSN 01616420, pages 2537 - 2548, XP055138976 | |
| OPPOSITION | - Farshad Abedi, Sanjeewa Wickremasinghe, Andrea J. Richardson, Enes Makalic, Daniel F. Schmidt, Sukhpal S. Sandhu, Paul N. Baird, Robyn H. Guymer, "Variants in the VEGFA Gene and Treatment Outcome after Anti-VEGF Treatment for Neovascular Age-related Macular Degeneration", Ophthalmology, Elsevier, (20130101), vol. 120, no. 1, doi:10.1016/j.ophtha.2012.10.006, ISSN 01616420, pages 115 - 121, XP055075853 | |
| OPPOSITION | - Schmidt-Erfurth Ursula, Kaiser Peter K., Korobelnik Jean-François, Brown David M., Chong Victor, Nguyen Quan Dong, Ho Allen C., Ogura Yuichiro, Simader Christian, Jaffe Glenn J., Slakter Jason S., Yancopoulos George D., Stahl Neil, Vitti Robert, Berliner Alyson J., Soo Yuhwen, Anderesi Majid, Sowade Olaf, Zeitz Oliver, Norenberg Christiane, Sandbrink Rupert, Heier Jeffrey S., "Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration", Ophthalmology, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (20140101), vol. 121, no. 1, doi:10.1016/j.ophtha.2013.08.011, ISSN 0161-6420, pages 193 - 201, XP093188729 | |
| OPPOSITION | - Ursula Schmidt-Erfurth et al., "Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration", Ophthalmology, (20142), vol. 121, doi:10.1016/j.ophtha.2013.08.011, page 1, XP093188729 | |
| OPPOSITION | - Altaweel Michael M., Daniel Ebenezer, Martin Daniel F., Mittra Robert A., Grunwald Juan E., Lai Michael M., Melamud Alexander, Morse Lawrence S., Huang Jiayan, Ferris Frederick L., Fine Stuart L., Maguire Maureen G., Williams David F., Beardsley Sara, Bennett Steven, Cantrill Herbert, Chan- Tram Carmen, Cheshier Holly, Damato Kathyrn, Davies John, Dev Sundeep, Enloe Julianne, Follano Gennaro, Gilbert Peggy, Johnson Jill, Jones Tori, Mayleben Lisa, Moos Martha, Neist Ryan, Oestreich Neal, Quiram Polly, Ramsay Robert, Ryan Edwin, Schindeldecker Stephanie, Snater John, Steele Trenise, Selders Dwight, Tonsfeldt Jessica, Valardi Shelly, Fish Gary Edd, Aguado Hank A., Arceneaux Sally, Arnwine Jean, Bell Kim, Bell Tina, Boleman Bob, Bradley Patricia, Callanan David, Coors Lori, Creighton Jodi, Crew Timothy, Cummings Kimberly, Dock Christopher, Duignan Karen, Fuller Dwain, Gray Keith, Hendrix Betsy, Hesse Nicholas, Jaramillo Diana, Jost Bradley, Lash Sandy, Lonsdale Laura, Mackens Michael, Mut, "Outcomes of Eyes with Lesions Composed of >50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)", Ophthalmology, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (20150201), vol. 122, no. 2, doi:10.1016/j.ophtha.2014.08.020, ISSN 0161-6420, pages 391 - 398.e5, XP055895128 | |
| OPPOSITION | - Rice Treva K., Schork Nicholas J., Rao D.C., "Chapter 12: Methods for Handling Multiple Testing", Rice Treva K., Schork Nicholas J., Rao D.C., D. C. Rao and C. Charles Gu, Genetic Dissection of Complex Traits, United States, Elsevier Science & Technology, (20080101), vol. 60, pages 293 - 308, doi:10.1016/S0065-2660(07)00412-9, ISSN 0065-2660, ISBN 9780123738837, XP009555977 | |
| OPPOSITION | - Ursula Schmidt-Erfurth, Victor Chong, Anat Loewenstein, Michael Larsen, Eric Souied, Reinier Schlingemann, Bora Eldem, Jordi Monés, Gisbert Richard, Francesco Bandello, "Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)", BRITISH JOURNAL OF OPHTHALMOLOGY, BMJ Publishing Group, GB, GB , (20140901), vol. 98, no. 9, doi:10.1136/bjophthalmol-2014-305702, ISSN 0007-1161, pages 1144 - 1167, XP055404243 | |
| OPPOSITION | - B. Kloeckener-Gruissem, D. Barthelmes, S. Labs, C. Schindler, M. Kurz-Levin, S. Michels, J. Fleischhauer, W. Berger, F. Sutter, M. Menghini, "Genetic Association with Response to Intravitreal Ranibizumab in Patients with Neovascular AMD", Investigative Ophthalmology & Visual Science, ¬Association for Research in Vision and Ophthalmology, etc.|, (20110701), vol. 52, no. 7, doi:10.1167/iovs.10-6080, ISSN 01460404, pages 4694 - 4702, XP055146555 | |
| OPPOSITION | - Bush William S., Moore Jason H., "Chapter 11: Genome-Wide Association Studies", PLOS Computational Biology, Public Library of Science, US, US , (20121201), vol. 8, no. 12, doi:10.1371/journal.pcbi.1002822, ISSN 1553-7358, page e1002822, XP093188788 | |
| OPPOSITION | - Patel Praveen, Devonport Helen, Sivaprasad Sobha, Ross Adam H, Walters Gavin, Gale Richard P, Lotery Andrew J, Mahmood Sajjad, Talks James S, Napier Jackie, "Aflibercept treatment for neovascular AMD beyond the first year: consensus recommendations by a UK expert roundtable panel, 2017 update", Clinical Ophthalmology, Volume 11, doi:10.2147/OPTH.S145732, ISSN 1177-5483, pages 1957 - 1966, XP093189899 | |
| OPPOSITION | - Agosta E; Lazzeri S; Orlandi P; Figus M; Fioravanti A; Di Desidero T; Sartini M S; Nardi M; Danesi R; Bocci G, "Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration", PHARMACOGENOMICS, Future Medicine, UK, UK , (20120701), vol. 13, no. 9, doi:10.2217/pgs.12.77, ISSN 1462-2416, pages 1037 - 1053, XP008164305 | |
| SEARCH | - PETER FRANCIS, "The influence of genetics on response to treatment with ranibizumab (Lucentis) for age-related macular degeneration: the Lucentis Genotype Study (an American Ophthalmological Society thesis).", TRANSACTIONS OF THE AMERICAN OPHTHALMOLOGICAL SOCIETY ANNUAL MEETING, (20111201), vol. 109, ISSN 0065-9533, pages 115 - 156, XP055075876 [A] 1-21,25-45 * abstract * | - |
| SEARCH | - VINSON M. WANG ET AL, "Suggestive association between PLA2G12A single nucleotide polymorphism rs2285714 and response to anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration", MOLECULAR VISION, (20121020), vol. 18, ISSN 1090-0535, pages 2578 - 2585, XP055146483 [X] 1,9,25,33 * abstract * | - |
| SEARCH | - KAWASHIMA YU ET AL, "Effects of aflibercept for ranibizumab-resistant neovascular age-related macular degeneration and polypoidal choroidal vasculopathy", GRAEFE'S ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, SPRINGER VERLAG, DE, vol. 253, no. 9, doi:10.1007/S00417-014-2838-5, ISSN 0721-832X, (20141113), pages 1471 - 1477, (20141113), XP035528379 [X] 9,33 * page 1472, column r, paragraph 3 * | |
| SEARCH | - MICHAEL B GORIN, "Genetic insights into age-related macular degeneration: Controversies addressing risk, causality, and therapeutics", MOLECULAR ASPECTS OF MEDICINE, vol. 33, no. 4, doi:10.1016/J.MAM.2012.04.004, ISSN 0098-2997, (20120427), pages 467 - 486, (20120427), XP028400782 [A] 1-21,25-45 * page 478, paragraph 1 * | |
| SEARCH | - FARSHAD ABEDI ET AL, "Variants in the VEGFA Gene and Treatment Outcome after Anti-VEGF Treatment for Neovascular Age-related Macular Degeneration", OPHTHALMOLOGY, (20130101), vol. 120, no. 1, doi:10.1016/j.ophtha.2012.10.006, ISSN 0161-6420, pages 115 - 121, XP055075853 [X] 9,33 * page 117, column l, paragraph 6 * | |
| SEARCH | - AGOSTA E ET AL, "Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration", PHARMACOGENOMICS,, (20120701), vol. 13, no. 9, doi:10.2217/PGS.12.77, ISSN 1462-2416, pages 1037 - 1053, XP008164305 [X] 9,33 * page 1042, column r, paragraph 2 * | |
